XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE OF FINANCIAL INSTRUMENTS
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
FAIR VALUE OF FINANCIAL INSTRUMENTS
NOTE 7: FAIR VALUE OF FINANCIAL INSTRUMENTS
Financial assets and liabilities measured at fair value on a recurring basis as of the date indicated below were presented on our unaudited condensed consolidated balance sheets as follows:
December 31, 2020
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents:
Money market funds$1,026,034 $— $— $1,026,034 
Cash and securities segregated under federal and other regulations:
U.S. Treasury securities134,994 — — 134,994 
Other current assets:
Equity securities - user-held fractional shares802,483 — — 802,483 
Equity securities - securities owned3,222 — — 3,222 
Total financial assets$1,966,733 $— $— $1,966,733 
Liabilities
Accounts payable and accrued expenses:
Equity securities - referral program liability
$695 $— $— $695 
Other current liabilities:
Equity securities - repurchase obligations
802,483 — — 802,483 
Total financial liabilities$803,178 $— $— $803,178 
September 30, 2021
(in thousands)Level 1Level 2Level 3Total
Assets
Cash equivalents:
Money market funds$4,006,138 $— $— $4,006,138 
Cash and securities segregated under federal and other regulations:
U.S. Treasury securities50,000 — — 50,000 
Other current assets:
Equity securities - user-held fractional shares1,530,971 — — 1,530,971 
Equity securities - securities owned22,769 — — 22,769 
Total financial assets$5,609,878 $— $— $5,609,878 
Liabilities
Accounts payable and accrued expenses:
Equity securities - referral program liability
$46 $— $— $46 
Other current liabilities:
Equity securities - repurchase obligations
1,530,971 — — 1,530,971 
Total financial liabilities$1,531,017 $— $— $1,531,017 
We measure our cash equivalents, securities segregated under federal and other regulations, equity securities owned by us for the promotional stock referral and fractional shares programs, and user-held fractional shares at fair value. Repurchase obligations in connection with our fractional shares program and equity securities that were awarded to our users as a part of our promotional stock referral program but had not been claimed as of December 31, 2020 and September 30, 2021 are also measured at fair value. We have evaluated the estimated fair value of financial instruments using available market information such as quoted market prices for the same instrument in active markets. Such instruments are classified within Level 1 of the fair value hierarchy.
During the nine months ended September 30, 2021, we did not have any transfers in or out of Level 3 assets or liabilities.
Convertible Notes and Warrant Liability
In February 2021, we issued two tranches of convertible notes (the “convertible notes”) and granted to each purchaser of the Tranche I convertible notes a warrant to purchase equity securities (the “warrant liability”) - see Note 12 for more information. We have elected the fair value option for both tranches of the convertible notes as we believe it best reflects their underlying economics. Under the fair value option, the convertible notes are initially measured at their issuance date estimated fair value and subsequently remeasured at their estimated fair value at the end of each reporting period. Upon the closing of the IPO, all of our outstanding convertible notes and warrants were reclassified from liability to equity. See Note 12 for more information.
For the three and nine months ended September 30, 2021, we recorded expense due to changes in fair value of $27.8 million and $1,918.6 million for the convertible notes in our unaudited condensed consolidated statements of operations, none of which is attributable to the change in the instrument-specific credit risk. We have elected to present the component related to accrued interest in the change in fair value of convertible notes and warrant liability.
For the three and nine months ended September 30, 2021, due to changes in fair value, we recorded income of $2.5 million and expense of $127.1 million for the warrant liability in our unaudited condensed consolidated statements of operations.
The following table sets forth a summary of the changes in the estimated fair value of our convertible notes and warrant liability:
(in thousands)Convertible notesWarrant liability
Beginning of period, January 1, 2021$— $— 
Issued during the period3,299,031 252,944 
Change in fair value1,918,565 127,092 
Reclassifications to equity(5,217,596)(380,036)
End of period, September 30, 2021$— $—